Wealth Enhancement Advisory Services
ATYR icon

Wealth Enhancement Advisory Services’s aTyr Pharma ATYR Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.38K Sell
527
-572
-52% -$11.1K ﹤0.01% 4212
2026
Q2 		$23.9K Buy
1,099
+710
+183% +$18.6K ﹤0.01% 4013
2026
Q1 		$13.2K Buy
+389
New +$13.1K ﹤0.01% 3539

Other funds holding ATYR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Kingswood Wealth Advisors
Kingswood Wealth Advisors San Diego, California $2.6B AUM 27.46% 1-Year Est. Return
Alpha Wealth Funds
Alpha Wealth Funds Park City, Utah $167M AUM 5.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Wealth Enhancement Advisory Services's ATYR Position: Q3 2026 in Review

Wealth Enhancement Advisory Services reduced its aTyr Pharma (ATYR) stake by 52% in Q3 2026, selling an estimated $11.1K and leaving 527 shares worth $5.38K. The position accounts for ﹤0.01% of the portfolio, ranked #4212.

Wealth Enhancement Advisory Services first reported a position in ATYR in Q1 2026 and has held it in 3 quarters since. The position peaked at $23.9K in Q2 2026. 26 funds tracked by Wall St. Rank hold ATYR as of Q3 2026.

  • Wealth Enhancement Advisory Services held 527 shares of aTyr Pharma worth $5.38K as of Q3 2026.
  • Wealth Enhancement Advisory Services sold 572 aTyr Pharma shares in Q3 2026, an estimated $11.1K.
  • aTyr Pharma made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #4212 holding.
  • Wealth Enhancement Advisory Services first reported a position in aTyr Pharma in Q1 2026 and has held it in 3 quarters since.
  • Wealth Enhancement Advisory Services's aTyr Pharma position peaked at $23.9K in Q2 2026.
  • 26 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.